Wake Forest University Health Sciences: Psoriasis trials

The registry lists 13 Psoriasis studies with Wake Forest University Health Sciences as lead sponsor. 1 are open to participants now and 2 have results posted.

Early Phase 1 2Phase 4 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Assessing Psoriasis Treatment OutcomesNot yet recruitingNCT07391423Not applicable
• Evaluating Treatment Resistant Dermatitis TaroIIRCompletedNCT03050294Phase 4Results posted
• Nurse Education in Subjects With Psoriasis Undergoing Treatment With AdalimumabCompletedNCT01435265Not applicableResults posted
• Adherence to OtezlaWithdrawnNCT05601492Early Phase 1
• Deucravacitinib Adherence StudyActive, not recruitingNCT05570955Not applicable
• Improving Disease SeverityCompletedNCT05391178Not applicable
• Use of Transcutaneous Electrical Nerve Stimulation for Reducing Biologic Injection Site Pain(TENS Study)Active, not recruitingNCT04058652Not applicable
• Iontophoresis in PsoriasisWithdrawnNCT03979664Early Phase 1
• A Priming Intervention to Increase Patient Willingness to Use Injectables for the Management of PsoriasisCompletedNCT03465696Not applicable
• Assessing Patient Confidence in Biologic MedicationsCompletedNCT03168347Not applicable
• Biologics Anchoring StudyCompletedNCT03026153Not applicable
• Oral Psoriasis Treatment Adherence and Intervention StudyCompletedNCT02850900Not applicable
• Prevalence of Sleep Disturbances in PsoriasisCompletedNCT00895375